10x Genomics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
10x Genomics (Nasdaq: TXG), a leader in single cell and spatial biology, has announced its participation in the upcoming Morgan Stanley 23rd Annual Global Healthcare Conference. The company's management team will engage in a fireside chat on September 10, at 11:30 a.m. Eastern Time.
Investors and interested parties can access the presentation through a live webcast on the company's investor relations website. The webcast recording will remain available for replay for at least 30 days following the event.
10x Genomics (Nasdaq: TXG), leader nelle tecnologie di single cell e biologia spaziale, ha comunicato la propria partecipazione al Morgan Stanley 23rd Annual Global Healthcare Conference. Il team di management terrà un intervento in formato fireside chat il 10 settembre alle 11:30 (Eastern Time).
Investitori e soggetti interessati potranno seguire la presentazione tramite webcast in diretta sul sito investor relations dell'azienda. La registrazione del webcast resterà disponibile in replay per almeno 30 giorni dopo l'evento.
10x Genomics (Nasdaq: TXG), referente en biología celular única y espacial, ha anunciado su participación en la Morgan Stanley 23rd Annual Global Healthcare Conference. El equipo directivo participará en una charla tipo fireside el 10 de septiembre a las 11:30 a.m. hora del Este (Eastern Time).
Los inversores y las personas interesadas podrán acceder a la presentación mediante una retransmisión en vivo (webcast) en la página de relaciones con inversores de la compañía. La grabación del webcast estará disponible para reproducción durante al menos 30 días después del evento.
10x Genomics (Nasdaq: TXG), 단일세포 및 공간생물학 분야의 선도기업이 Morgan Stanley 23rd Annual Global Healthcare Conference에 참여한다고 발표했습니다. 경영진은 동부 표준시 기준 9월 10일 오전 11시 30분에 파이어사이드 채팅에 참석할 예정입니다.
투자자 및 관심 있는 분들은 회사 투자자 관계 웹사이트를 통해 라이브 웹캐스트로 발표를 시청할 수 있습니다. 웹캐스트 녹화본은 행사 후 최소 30일간 다시보기로 제공됩니다.
10x Genomics (Nasdaq: TXG), leader en biologie cellulaire unique et spatiale, a annoncé sa participation à la Morgan Stanley 23rd Annual Global Healthcare Conference. L'équipe dirigeante participera à une discussion informelle (fireside chat) le 10 septembre à 11h30, heure de l'Est (Eastern Time).
Les investisseurs et personnes intéressées pourront suivre la présentation via un webcast en direct sur le site relations investisseurs de la société. L'enregistrement du webcast restera disponible en replay pendant au moins 30 jours après l'événement.
10x Genomics (Nasdaq: TXG), ein führendes Unternehmen im Bereich Einzelzell- und Spatial-Biologie, hat seine Teilnahme an der Morgan Stanley 23rd Annual Global Healthcare Conference bekanntgegeben. Das Management-Team wird am 10. September um 11:30 Uhr Eastern Time an einem Fireside-Chat teilnehmen.
Investoren und Interessierte können die Präsentation über einen Live-Webcast auf der Investor-Relations-Webseite des Unternehmens verfolgen. Die Aufzeichnung des Webcasts bleibt mindestens 30 Tage nach der Veranstaltung zum Abruf verfügbar.
- None.
- None.
Interested parties may access a live webcast of the fireside chat on the "Investors" section of the company's website at: https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 30 days after the event.
About 10x Genomics
10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated research solutions include instruments, consumables, and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience, and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn, X (Twitter), Facebook, Bluesky or YouTube.
Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, our website (www.10xgenomics.com), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.
Contacts
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference-302540179.html
SOURCE 10x Genomics, Inc.